Cardiology NewsRivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APSOctober 15, 2019Thrombosis
Cardiology NewsTicagrelor monotherapy tops DAPT for high-risk PCI patientsSeptember 29, 2019Interventional Cardiology & SurgeryThrombosis
Cardiology NewsOlder IBD patients are most at risk of postdischarge VTESeptember 10, 2019ThrombosisVenous Thromboembolism
Cardiology NewsPost-TAVR anticoagulation alone fails to cut stroke risk in AFibAugust 19, 2019Interventional Cardiology & SurgeryArrhythmias & EPThrombosis
Cardiology NewsResearchers combine genetic and clinical factors in new VTE risk scoreJuly 31, 2019ThrombosisVenous Thromboembolism
Cardiology NewsDoes endovascular thrombectomy benefit stroke patients with large infarcts?July 29, 2019StrokeInterventional Cardiology & SurgeryThrombosis
Cardiology NewsNOACs benefit early stage chronic kidney disease patientsJuly 15, 2019ThrombosisArrhythmias & EP
Cardiology NewsRisk of atrial fibrillation 900% higher with cancerJuly 11, 2019ThrombosisArrhythmias & EP
Cardiology NewsNo reduction in PE risk with vena cava filters after severe injuryJuly 9, 2019Venous ThromboembolismThrombosis
Cardiology NewsRivaroxaban tied to higher GI bleeding than other NOACsJune 17, 2019ThrombosisVenous Thromboembolism
Cardiology NewsAntibody hierarchy may drive development of SLE vs. antiphospholipid syndromeJune 14, 2019Thrombosis
Cardiology NewsTicagrelor doesn’t beat clopidogrel in postfibrinolysis STEMIApril 15, 2019ThrombosisAcute Coronary Syndromes
